|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.02 EUR | +1.25% |
|
-1.46% | +7.16% |
| Apr. 15 | Faron Pharmaceuticals reappoints former finance chief on interim basis | AN |
| Feb. 14 | Biohit Oyj Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Biohit Oyj announced CEO Päivi Siltala has resigned. The board of directors of the company has appointed CFO Jussi Hahtela the new CEO. Hahtela will start in the new role immediately.
Master of Social Sciences Jussi Hahtela (b. 1973) has worked at the company as CFO from June 2021. He has previously worked in Nordea for example as chief strategist and Head of FX sales Finland.
| 1st Jan change | Capi. | |
|---|---|---|
| +7.16% | 32.72M | |
| +7.13% | 7.91B | |
| -3.15% | 4.66B | |
| -9.18% | 2.84B | |
| +1.11% | 2.03B | |
| -26.56% | 1.12B | |
| -22.71% | 759M | |
| -13.49% | 755M | |
| -56.85% | 682M | |
| -24.66% | 671M |
BIOHIT OYJ 
